- Home
- IINN vs DXR Comparison
IINN vs DXR Comparison
Compare IINN & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IINN
- DXR
- Stock Information
- Founded
- IINN 2018
- DXR 1970
- Country
- IINN Israel
- DXR United States
- Employees
- IINN N/A
- DXR N/A
- Industry
- IINN Medical/Dental Instruments
- DXR Medical/Dental Instruments
- Sector
- IINN Health Care
- DXR Health Care
- Exchange
- IINN Nasdaq
- DXR Nasdaq
- Market Cap
- IINN 40.4M
- DXR 46.9M
- IPO Year
- IINN 2021
- DXR N/A
- Fundamental
- Price
- IINN $1.16
- DXR N/A
- Analyst Decision
- IINN Strong Buy
- DXR Strong Buy
- Analyst Count
- IINN 1
- DXR 1
- Target Price
- IINN $2.00
- DXR $25.00
- AVG Volume (30 Days)
- IINN 270.6K
- DXR 6.1K
- Earning Date
- IINN 10-01-2025
- DXR 01-01-0001
- Dividend Yield
- IINN N/A
- DXR N/A
- EPS Growth
- IINN N/A
- DXR 3.46
- EPS
- IINN N/A
- DXR 0.36
- Revenue
- IINN $289,000.00
- DXR $66,306.00
- Revenue This Year
- IINN N/A
- DXR N/A
- Revenue Next Year
- IINN $3,100.00
- DXR N/A
- P/E Ratio
- IINN N/A
- DXR $35.58
- Revenue Growth
- IINN N/A
- DXR N/A
- 52 Week Low
- IINN $0.40
- DXR $6.55
- 52 Week High
- IINN $1.65
- DXR $14.00
- Technical
- Relative Strength Index (RSI)
- IINN 45.32
- DXR 54.51
- Support Level
- IINN $1.14
- DXR $12.70
- Resistance Level
- IINN $1.28
- DXR $14.00
- Average True Range (ATR)
- IINN 0.07
- DXR 0.51
- MACD
- IINN -0.01
- DXR -0.14
- Stochastic Oscillator
- IINN 16.67
- DXR 42.43
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.